Bazarbachi, Ali http://orcid.org/0000-0002-7171-4997
Labopin, Myriam http://orcid.org/0000-0003-4514-4748
Blaise, Didier http://orcid.org/0000-0002-5684-9447
Forcade, Edouard
Socié, Gerard http://orcid.org/0000-0002-2114-7533
Berceanu, Ana
Angelucci, Emanuele http://orcid.org/0000-0002-6512-6080
Bulabois, Claude Eric
Kröger, Nicolaus http://orcid.org/0000-0002-2961-4183
Rambaldi, Alessandro http://orcid.org/0000-0002-3739-7502
Ceballos, Patrice
Mielke, Stephan http://orcid.org/0000-0002-8325-9215
El Cheikh, Jean http://orcid.org/0000-0003-2846-9428
Yakoub-Agha, Ibrahim
Savani, Bipin
Spyridonidis, Alexandros http://orcid.org/0000-0003-3097-2532
Nagler, Arnon
Mohty, Mohamad
Article History
Received: 10 April 2020
Revised: 15 September 2020
Accepted: 22 September 2020
First Online: 6 October 2020
Compliance with ethical standards
:
: AB received honorarium from Jazz, Adienne, and Sanofi. MM received honorarium from Jazz, Riemser, and Sanofi. EA reports personal fees from Novartis, Jazz Pharmaceuticals, Bluebird Bio, Roche, Celgene, Vertex Pharmaceuticals, and CRISPR Therapeutics all outside the submitted work. All remaining authors do not have any conflicts of interest.